Mesoblast (MEOBF) Total Debt (2018 - 2026)
Mesoblast's (MEOBF) quarterly Total Debt came in at $10.6 million in Q2 2026, down 80.43% year-over-year from $54.2 million in Q2 2025, and down 84.12% quarter-over-quarter from $66.7 million in Q4 2025.
Analysis
Mesoblast (MEOBF) Total Debt (2018 - 2026) Analysis & Trends
Mesoblast has disclosed Total Debt across 9 years of filings, most recently posting $10.6 million for Q2 2026.
- In Q2 2026, Total Debt fell 80.43% year-over-year to $10.6 million; the TTM figure through Jun 2026 stood at $10.6 million (down 80.43% YoY), while the FY2026 annual figure was $10.6 million, down 80.43% from the prior year.
- Total Debt came in at $10.6 million for Q2 2026 at Mesoblast, down from $66.7 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $66.7 million in Q4 2025 to a low of $5.0 million in Q2 2022.
- Average Total Debt over 5 years is $17.2 million, with a median of $7.9 million recorded in 2023.
- Year-over-year, Total Debt plunged 90.57% in 2022 and surged 290.67% in 2025.
- Over 5 years, Total Debt stood at $5.9 million in 2022, then jumped by 43.72% to $8.5 million in 2023, then jumped by 105.12% to $17.5 million in 2024, then soared by 281.25% to $66.7 million in 2025, then sank by 84.12% to $10.6 million in 2026.
- Per Business Quant data, the three most recent Total Debt figures were $10.6 million in Q2 2026, $66.7 million in Q4 2025, and $54.2 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 586.20 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 156.40 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 50.15 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 112.43 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 93.88 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 847.62 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | 10.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.60 Mn |
| Dec 31, 2025 | 66.74 Mn |
| Jun 30, 2025 | 54.16 Mn |
| Dec 31, 2024 | 17.51 Mn |
| Jun 30, 2024 | 13.86 Mn |
| Dec 31, 2023 | 8.53 Mn |
| Jun 30, 2023 | 5.95 Mn |
| Mar 31, 2023 | 7.31 Mn |
| Dec 31, 2022 | 5.94 Mn |
| Sep 30, 2022 | 5.49 Mn |
| Jun 30, 2022 | 5.02 Mn |
| Mar 31, 2022 | 5.52 Mn |
| Dec 31, 2021 | 5.20 Mn |
| Sep 30, 2021 | 53.85 Mn |
| Jun 30, 2021 | 53.20 Mn |
| Mar 31, 2021 | 52.67 Mn |
| Dec 31, 2020 | 41.57 Mn |
| Sep 30, 2020 | 34.89 Mn |
| Jun 30, 2020 | 32.46 Mn |
| Mar 31, 2020 | 27.00 Mn |